49 research outputs found

    Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

    Get PDF
    Background The efficacy and safety of opicapone, a once-daily catechol-O-methyltransferase inhibitor, have been established in two large randomized, placebo-controlled, multinational pivotal trials. Still, clinical evidence from routine practice is needed to complement the data from the pivotal trials. Methods OPTIPARK (NCT02847442) was a prospective, open-label, single-arm trial conducted in Germany and the UK under clinical practice conditions. Patients with Parkinson’s disease and motor fluctuations were treated with opicapone 50 mg for 3 (Germany) or 6 (UK) months in addition to their current levodopa and other antiparkinsonian treatments. The primary endpoint was the Clinician’s Global Impression of Change (CGI-C) after 3 months. Secondary assessments included Patient Global Impressions of Change (PGI-C), the Unified Parkinson’s Disease Rating Scale (UPDRS), Parkinson’s Disease Questionnaire (PDQ-8), and the Non-Motor Symptoms Scale (NMSS). Safety assessments included evaluation of treatment-emergent adverse events (TEAEs) and serious adverse events (SAEs). Results Of the 506 patients enrolled, 495 (97.8%) took at least one dose of opicapone. Of these, 393 (79.4%) patients completed 3 months of treatment. Overall, 71.3 and 76.9% of patients experienced any improvement on CGI-C and PGI-C after 3 months, respectively (full analysis set). At 6 months, for UK subgroup only (n = 95), 85.3% of patients were judged by investigators as improved since commencing treatment. UPDRS scores at 3 months showed statistically significant improvements in activities of daily living during OFF (mean ± SD change from baseline: − 3.0 ± 4.6, p < 0.0001) and motor scores during ON (− 4.6 ± 8.1, p < 0.0001). The mean ± SD improvements of − 3.4 ± 12.8 points for PDQ-8 and -6.8 ± 19.7 points for NMSS were statistically significant versus baseline (both p < 0.0001). Most of TEAEs (94.8% of events) were of mild or moderate intensity. TEAEs considered to be at least possibly related to opicapone were reported for 45.1% of patients, with dyskinesia (11.5%) and dry mouth (6.5%) being the most frequently reported. Serious TEAEs considered at least possibly related to opicapone were reported for 1.4% of patients. Conclusions Opicapone 50 mg was effective and generally well-tolerated in PD patients with motor fluctuations treated in clinical practice. Trial registration Registered in July 2016 at clinicaltrials.gov (NCT02847442)

    Ultrathin-layer chromatography on SiO2, Al2O3, TiO2, and ZrO2 nanostructured thin films

    No full text
    We explored four different inorganic oxides and determined their merits in miniaturized planar chromatography. Despite progression of chromatographic techniques over several decades, such alternatives to traditional planar silica gel stationary phases have not been fully evaluated. Glancing angle deposition (GLAD) provided an excellent platform for engineering nanostructured thin films in these materials for ultrathin-layer chromatography (UTLC). Separations of carotenoids and synthetic food dyes were used to investigate the attributes of SiO2, Al2O3, TiO2, and ZrO2 GLAD UTLC media. These anisotropic high surface area thin films possessed similar channel-like features but different chromatographic properties. TiO2 and ZrO2 media were especially interesting since analyte retention could be modified through simple oxidation heat treatments and UV irradiation. Generally, oxidation reduced analyte retention while UV exposure increased retention. Changes in retention factor as large as \u3b4hRF~40 (for Acid Red 14 on titanium oxide) were achieved. Food dye mixtures were applied using consumer inkjet printers as per the Office Chromatography concept and separation performance was quantified using advanced video instrumentation designed for miniaturized plates. Enhanced time-resolved UTLC methods were used to calculate figures of merit from recorded dye separation videos. Small theoretical plate heights (<4\u3bcm) and low limits of detection (<2ng per zone for the food dye tartrazine) were measured. The combination of engineered GLAD UTLC plates, inkjet application of analyte spots, time-resolved UTLC, and custom analysis algorithms enabled some of the best performance achieved on GLAD UTLC layers. Separations on the inorganic oxide thin films were also successfully hyphenated with electrospray ionization mass spectrometry for the first time. This investigation demonstrates the utility of alternative inorganic oxide GLAD UTLC media and probes avenues of expanding the capabilities of miniaturized planar chromatography. \ua9 2013 Elsevier B.V.Peer reviewed: YesNRC publication: Ye
    corecore